Table 4.

Percent of predicted anti-Xa C_ss >1.2 IU ml⁻¹ or percent of predicted anti-Xa C_ss <0.5 IU ml⁻¹ when general medical unit and ICU patients receive enoxaparin at different infusion rates of 8.3, 5.8, 5.0 and 4.2 IU kg⁻¹ h⁻¹ for subjects in each renal function group

		General medical unit patients		ICU patients
Infusion rate (IU kg−1 h−1)	CrCL (ml min−1)	Mean % of Css < 0.5 IU ml−1	Mean % of Css > 1.2 IU ml−1	Mean % of Css < 0.5 IU ml−1	Mean % of Css > 1.2 IU ml−1
8.3	< 30	6.74	54.4	4.1	65.8
	30–50	11.9	42.7	7.4	55.5
	> 50	22.4	28	13.3	44
5.8	< 30	16.6	32.3	10.97	46.1
	30–50	28.2	21.6	16.8	36.2
	> 50	43.8	11.6	25.8	22.9
5.0	< 30	23.7	24.3	16.8	35.1
	30–50	36.8	15.3	24.2	26.4
	> 50	53.3	7.59	36.8	14.5
4.2	< 30	32.8	16.3	24.1	26.4
	30–50	47.4	9.93	32.4	18.4
	> 50	63.8	4.47	48.0	9.13

ICU, Intensive care unit; C_ss, steady-state anti-Xa concentration.